Dr. Madhusudan (Madhu) Grover is a physician scientist at Mayo Clinic known for his groundbreaking contributions in pathobiology of irritable bowel syndrome (IBS) and gastroparesis.  

Madhu graduated from Maulana Azad Medical College in New Delhi, India. He then migrated to the U.S. for internal medicine residency at Michigan State University. He took a sabbatical to work with Dr. Douglas Drossman (ex-president, Rome Foundation) at UNC. During that time, Madhu published over 8 primary articles, making a name for himself as an emerging candidate in neurogastroenterology. He joined clinical and research fellowship at Mayo Clinic in 2009.  

At Mayo, with a significant interest in translational career trajectory, Madhu took a critical step into basic science research. Working with Dr. Gianrico Farrugia (ASCI member and current president of Mayo Clinic), Madhu discovered enteric nervous system and immune changes in gastroparesis (~500 citations). This project led to additional publications and the 2014 Ken Heaton award for the field's most impactful publication. Immediately after fellowship, Madhu started charting an independent trajectory. He was particularly intrigued by the role of microbiome, proteases, and barrier in IBS. These studies started with K23 and R03 funding from NIDDK, and subsequently became the foundation for 2 ongoing R01 awards. Madhu’s program has also received support from AGA, DoD and industry.  

Madhu was promoted to Associate Professor of Medicine and Physiology in 2021, became AGA Fellow in 2022. Madhu has 110 publications including top journals such as Cell, Nature microbiology, Nature communications, Gastroenterology, Gut, and CGH. He has given 40 invited talks and mentored 26 students and fellows. He is involved in service of the field as board member of Rome Foundation and editor-in-chief of Npj Gut and Liver. He is also head of the GI motility group at Mayo Clinic and program director for the motility fellowship.